Literature DB >> 9749415

Prenatal diagnosis of limb-body wall complex.

H Negishi1, M Yaegashi, E H Kato, H Yamada, K Okuyama, S Fujimoto.   

Abstract

OBJECTIVE: To evaluate prenatal diagnosis of limb-body wall complex (LBWC) by ultrasonography in eight cases. STUDY
DESIGN: The diagnosis was based on two of the following: exencephaly/encephalocele with facial clefts, thoracoschisis and/or abdominoschisis and limb defect. The ultrasonographic findings were compared with the autopsy findings in each case.
RESULTS: The average weeks of gestation at which malformations were diagnosed by ultrasonography was 21.7 +/- 4.7 (mean +/- SD, n = 8). All eight fetuses were diagnosed as having characteristic abnormalities and six of them as having scoliosis by ultrasonography. Four of the eight were examined for maternal serum alpha-fetoprotein (MSAFP); the levels exceeded 2.5 multiples of the mean according to the standard value at our hospital. Chromosomal analysis was performed for six cases and revealed that they were normal in karyotype. All eight cases showed abdominoschisis, scoliosis and abnormalities of the lower extremities. A single umbilical artery was present in seven cases (87.5%), and a short umbilical cord was present in seven (87.5%).
CONCLUSION: Ultrasonographic detection of abdominoschisis, scoliosis abnormalities of the lower extremities, a single umbilical artery and a short umbilical cord is important for the prenatal diagnosis of LBWC. An extremely elevated level of MSAFP is also indicative of the complex.

Entities:  

Mesh:

Year:  1998        PMID: 9749415

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Prenatal MRI evaluation of limb-body wall complex.

Authors:  Elisa Aguirre-Pascual; Monica Epelman; Ann M Johnson; Nancy A Chauvin; Beverly G Coleman; Teresa Victoria
Journal:  Pediatr Radiol       Date:  2014-06-14

2.  Anatomy-based diagnostic criteria for complex body wall anomalies (CBWA).

Authors:  Nieves Martín-Alguacil
Journal:  Mol Genet Genomic Med       Date:  2020-08-27       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.